D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

Additional

code for adverse effect, if applicable, to identify drug (T45.515, T45.525)

Applicable To

Drug-induced hemorrhagic disorder
Hemorrhagic disorder due to increase in anti-IIa
Hemorrhagic disorder due to increase in anti-Xa
Hyperheparinemia

GEM Conversion to ICD-9 CM


MDC / MS-DRG Reference


Back Reference of Diagnostic Codes


Sibling Codes


Parent Sibling Codes


View in Tabular

Code Title
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
D65-D69 Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
D68 Other coagulation defects
D68.3 Hemorrhagic disorder due to circulating anticoagulants
D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
Use Additional
code for adverse effect, if applicable, to identify drug (T45.515, T45.525)

Applicable to
Drug-induced hemorrhagic disorder
Hemorrhagic disorder due to increase in anti-IIa
Hemorrhagic disorder due to increase in anti-Xa
Hyperheparinemia